Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal ...

The 'Dancing with the Stars' contestant lost 20 lbs. from a GLP-1 medication but stopped taking it after experiencing ...

The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish ...

Eli Lilly shares have room to keep going as GLP-1 drugs spread their reach.

Novo Nordisk cuts Wegovy's price and commits fully to its upcoming weight-loss pill to stay competitive in the fast-growing ...

A newly aggressive Novo Nordisk is undercutting rival Eli Lilly on the price of its weight loss drugs for cash-paying ...

Originally developed for diabetes, GLP-1 drugs like Ozempic are showing remarkable potential in combating addiction. Emerging ...

It's the kind of promise that stops thumbs mid-scroll: "Take Molecule and forget food exists." Viral TikTok clips show ...

"Developing new ways to treat these patients is of the utmost importance," Dr. Casey H. Halpern, a senior author of the study ...

Amid a rapid rise in the use of Semaglutide for weight loss among Pakistani celebrities and well-known public figures, ...

Celebrity endorsements by Elon Musk and Serena Williams have pushed weight loss medication into the mainstream. Demand is so ...

A GLP-1/glucagon dual agonist induced significant weight loss and improved multiple cardiometabolic parameters for adults ...